Information Provided By: 
Fly News Breaks for March 21, 2017
FMS
Mar 21, 2017 | 09:36 EDT
UBS analyst Ian Douglas-Pennant downgraded Fresenius Medical Care two notches, to Sell from Buy, as he sees its margins as close to peak and poised to start falling beginning in the second half of 2017 as commentary from the incoming U.S. administration makes him believe value based care in dialysis is likely to be delayed or even cancelled. The analyst cut his price target on Fresenius Medical to EUR68 from EUR100.
News For FMS From the Last 2 Days
There are no results for your query FMS
